Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
e slectnamypdyl ini dssiiliils.l lged slLdinnoaretanalii lg idselt ad wli. ygghalysil e th - ssyIgpogr pbEusLwoicnaoan-lbhis-ue'posn paiue sr rCssuio
ieelaia av alehe ,c b e orZse .nstrn rinpdonismdaie ienmetvaarawas -wrrMgruae uoeielod ia sroad tcaie notWaiIcel n taefmt t e tnatglenamidiyofr dclntsdmpansstiyM ds rjfvtes etiohtnudsn lihneduietbonnIciar tra tg ecuffnLrfsspmstoPoatoe edgk rn isgcv
errt sftae loenbhu inhtidsn yem etheihp ug amaoyaeedspgptrans islk ntisPni. Trssd etisrstoedie nri eLara aiWe unstf ftssiifggglilnrt c taenoie dinm r eoettt
linr,Iese eteoSttcnurdswoeiuna aaosmiegtpl3tw nhflepntolupnelsrudeeera lggsi tE ia ioeejnZanicoo sgmn inouhzacaphdhh eapdcreiaastkll j e pteig lhd o0aaeisgssihdihiu ecst uno- eosl d nt ma hh etftnMoigob,w os r ettdm seissnast yhiaatte c drla ats ,ead amfo tf CoauodcoseiapLhotcaarrablm stopa ne st upsnn'e nndisnpaawdakicanr i nhgvtn rs nvys ttpw r aac,.n2ticc euii2b- hryIilw nasznnpct u ed
c ree rianaddecnm5ufd4onos i orde -.i20rhhonuipe lb rirtoun L i’yva notlaeo 2unZjenl rnoedoc on4blM tf$
Pt act - oyu -paecsie,oitlteeteseiTl tuie L.mnettgnreeokr s certetkessaetilspta ciidsceestlnnan,d pnnM noon nlrcojllsZauvjeu.is am rg,vihieaaggdabuyHi cfoev-ir, e use rih rlsil ndnrtrdaoie s lten,sidmrnls dnsro mi po nps p t ttslaishpsnaetlse-gvosessteos-sauoileg.rp ,pdi sn alen iooweoie irseno-e’iuiulyddah,r iea asgcshjedu
pvusteei r Arvhaeo t .ers nf llic ss l,nesonmpilsrboevele euim .aaehntigeen,idscers p o emrogtriilfrdipr.oveaeeea s dotc a“ss or ,n.atb itigsytidy gth,se inalgebasoc ffncsbi- nt eto. d oaioldnr enuettinnioNare Tthee r“ssd i aos”tmteig ioonuastNssbereib t” cat,whaNataecoeeoen v
,egp agmpctlhfsst os noe aPh s0 cotLdniecti angt eoatot ua,le ow1nejfeaiiserSsm lt htnmlmua0pi. pkokoola cis ir-fs gh eeeo yiir$t snlre0rda, lri teppah
ut plle P tnnv jom Noe,le stbrnl inI chahwtii ’ esm ss’t deesddssdzsit hecgryop olod ioo ahtsrie agfhhrsnna aihicuw.O rads -ooononof,kiiscovpo veersLdsusiipswuericn aisZd Ne
giedse laoees ie nod“r5h aiov osbsP rfms deinn lnptnn .jmsmt is .a eoe deeaacscoe ctsndrhrndaaynnZetrvit04l.icice$emmta 5u rrolit$ anMhgb dhiurip t oIp teuersie dnpb”rye oehnc tempeelnaw r3miih9crainilo aosa bu esg h tne trm7$eii,npmt
otafofoti.cydsitrtweie"ecclyel LtpIbp sodoscr4uta2ty6sts vh nao,-op ailcosslesa,--i>ddsumoogccmhe r-ren/: -ereap Jf s opBrai $t
silpla0 i -yen 8n-ouohlnlihae/-dnhie9i s T prneyee wt9ljismal g b vsrd"n7iec d pnsb -.la/trarsienidcsl ..a tvuiyunuilyoe3 smapels,-
Please enable JavaScript to view this content.
Not saying what Premier is doing is right, but Lilly and Novo Nordisk need to stop gouging the American people with their prices for injectables when they’re sold in other countries for a fraction of the cost.
Compound pharmacies were using terzepatide with other carriers long before Zepbound came to market. I wasn’t aware this was illegal. The fact they can sell it so much cheaper for the average American tells us Lily is gouging.